Home > News > featured news > Medisafe Launches New SaMD Technology to Enhance Business Solutions

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

Medisafe Launches New SaMD Technology to Enhance Business Solutions

Medisafe | January 05, 2023 | Read time : 01:00 min

Medisafe Launches
Medisafe, a digital therapeutics firm focused on medication engagement, recently introduced SaMD technology. This announcement comes months after receiving ISO 13485:2016 accreditation for medical devices and ISO 27001:2013 certification for pharmaceutical and digital health platforms. These international registrations demonstrate Medisafe's clinical management and patient engagement leadership.

With the market for disease management software growing, Medisafe's development shows that the company is committed to following the law, going above and beyond what is expected, and being at the forefront of SaMD development.

The achievements made by Medisafe in the past year to better serve patients, doctors, and pharma partners have earned the company a great deal of pride. Medisafe remarked that the most recent announcement of registering as a SaMD is not only a crucial step in the company's development, but it is also essential that it anticipate and address changing customer and industry needs, both regulated and unregulated, as leaders and innovators in digital therapeutics.

Medisafe continues to focus on non-regulated business-building solutions that exceed the needs of pharma, HUBs, providers, and patients.

Through an interoperable, individualized, and patient-centric approach to digital patient connectivity, Medisafe's end-to-end Care Connector platform enables organizations to effectively engage with patients throughout the medication journey, supporting pharma's vision for a more digitally enhanced future. More than 10 million registrants utilize and rely on Medisafe's platform and digital drug companion to manage their medications, validating the value it brings to patients.

Meanwhile, Medisafe will attend the 41st Annual J.P. Morgan Healthcare Conference, which will take place on January 9–12, 2023, in San Francisco, CA, USA.

About Medisafe


Medisafe® is a premier personalized medication management platform that connects users to their families (and soon, their doctors) for support, encouragement, and expertise to provide customized notifications for visits and refills, prescription updates, personalized health advice, and discounts. It monitors blood pressure and glucose to show the benefits of taking drugs as prescribed. The company improves patient happiness and care by preventing inaccurate or missed dosages.

Spotlight

Philips Image Guided Therapy Mobile C-arm System 1000 - Zenition 10

Power the future of routine surgeries. High-quality imaging, high uptime and efficient workflow in a powerfully compact design.

More featured news

Spotlight

Philips Image Guided Therapy Mobile C-arm System 1000 - Zenition 10

Power the future of routine surgeries. High-quality imaging, high uptime and efficient workflow in a powerfully compact design.

Related News

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

FUTURE OF HEALTHCARE, MEDICAL DEVICES

WellSky® Introduces Enhanced Intelligence to the Discharge Process in CarePort Suite of Solutions to Facilitate Superior Care Transitions

Businesswire | April 21, 2023

WellSky, a leading health and community care technology company, today announced expanded capabilities in its CarePort suite of care transition solutions. These new enhancements equip discharge planners, care managers, and care coordinators with enhanced intelligence at the point of discharge to help them make more informed decisions and ensure patients receive the best possible care and support as they transition from the hospital to home or another care setting. WellSky and CarePort recently expanded its network with the acquisition of Curaspan. Curaspan clients using CarePort Discharge can now take advantage of an expanded solution set. “We're thrilled to offer our clients, including those in our newly expanded network available through Curaspan, capabilities to better engage patients and families and enhance their care planning and decision making throughout the discharge process,” said Dr. Lissy Hu, president of connected networks at WellSky. “Through these enhancements, WellSky is enabling care providers to deliver the right care, at the right time, in the right setting to achieve better health outcomes.” By extending CarePort Connect into the care transitions solutions, providers gain seamless access directly from their discharge planning workflows. This access delivers a deeper knowledge of past post-acute care utilization which is critical to help providers determine the appropriate level of care needed post-discharge and create a care plan tailored to the patient's specific needs. Accessing clinical data and encounter history at a patient’s most vulnerable point of transition can help reduce hospital readmissions and connect patients to the most appropriate care. CarePort Guide, available in CarePort Discharge, gives hospitals and health systems access to a more robust patient choice tool to assist patients and families in selecting high-quality post-acute care. CarePort Guide provides access to proprietary post-acute quality scores, highlights high-performing post-acute networks and collaboratives, and offers more robust agency profiles and guides, all sharable via text and email. By increasing patient satisfaction with the discharge process and reducing discharge delays, CarePort Guide brings a superior post-acute care selection tool to the market and can increase the number of patients attending in-network skilled nursing facilities by 7%. About WellSky® WellSky is one of America’s largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care. Our proven software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations scale processes, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to build healthy, thriving communities.

Read More

HEALTHCARE ANALYTICS

New Life Health & Concierge Selects eClinicalWorks EHR and healow for Improved Scalability, Reduced Costs, and Telehealth Services

Businesswire | May 29, 2023

eClinicalWorks®, the largest ambulatory cloud EHR, announced that New Life Health & Concierge, a primary care practice specializing in patient-centered concierge medicine, selected eClinicalWorks and healow to improve efficiency, drive patient acquisition, enhance patient engagement and lower costs. With eClinicalWorks and healow, the newly founded Fort Worth, TX based New Life Health & Concierge can leverage tools that will allow the company to spend more time focusing on improving and expanding their business and less time organizing their front and back office. In addition to eClinicalWorks Cloud EHR, healow® TeleVisits® helps the organization deliver in-office quality remotely, and improve safety, while also providing access to healthcare and convenience for patients and providers. “As a relatively new practice, we want to start off on the right foot and provide our patients with a seamless experience,” said Catherine C Wilson, FNP-BC of New Life Health & Concierge. “eClinicalWorks Cloud EHR provides us with the strong base we need to keep all the moving parts of starting a new business in line. eClinicalWorks makes it easy for our providers to keep up with the influx of new patients while organizing all their data and keeping costs low.” eClinicalWorks Project Kickstart helps startups like the New Life Health & Concierge thrive with Special pricing on eClinicalWorks’ suite of health IT features Marketing expertise, including website building, local SEO and social media Access to eClinicalWorks' top features, such as a fully integrated EMR and billing, PRISMA, online booking, healow TeleVisits and more. About eClinicalWorks eClinicalWorks was founded in 1999 to help digitize paper charts for ambulatory practices. Today, eClinicalWorks leads the nation in innovation with cloud-based solutions for Electronic Health Records and Practice Management. In addition, we help ambulatory practices, specialists, health centers, urgent care facilities, and hospital systems manage their revenue cycle, patient relationships, and Population Health initiatives. More than 150,000 providers and nearly 1 million medical professionals rely upon the power and scalability of the eCW Cloud for flexible clinical documentation, better front-office workflows, and more efficient billing driven by Robotic Process Automation. We combine innovation, leading-edge technology, and a commitment to patient safety to enable practices to grow and thrive amid the challenges of 21st-century healthcare

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

FUTURE OF HEALTHCARE, MEDICAL DEVICES

WellSky® Introduces Enhanced Intelligence to the Discharge Process in CarePort Suite of Solutions to Facilitate Superior Care Transitions

Businesswire | April 21, 2023

WellSky, a leading health and community care technology company, today announced expanded capabilities in its CarePort suite of care transition solutions. These new enhancements equip discharge planners, care managers, and care coordinators with enhanced intelligence at the point of discharge to help them make more informed decisions and ensure patients receive the best possible care and support as they transition from the hospital to home or another care setting. WellSky and CarePort recently expanded its network with the acquisition of Curaspan. Curaspan clients using CarePort Discharge can now take advantage of an expanded solution set. “We're thrilled to offer our clients, including those in our newly expanded network available through Curaspan, capabilities to better engage patients and families and enhance their care planning and decision making throughout the discharge process,” said Dr. Lissy Hu, president of connected networks at WellSky. “Through these enhancements, WellSky is enabling care providers to deliver the right care, at the right time, in the right setting to achieve better health outcomes.” By extending CarePort Connect into the care transitions solutions, providers gain seamless access directly from their discharge planning workflows. This access delivers a deeper knowledge of past post-acute care utilization which is critical to help providers determine the appropriate level of care needed post-discharge and create a care plan tailored to the patient's specific needs. Accessing clinical data and encounter history at a patient’s most vulnerable point of transition can help reduce hospital readmissions and connect patients to the most appropriate care. CarePort Guide, available in CarePort Discharge, gives hospitals and health systems access to a more robust patient choice tool to assist patients and families in selecting high-quality post-acute care. CarePort Guide provides access to proprietary post-acute quality scores, highlights high-performing post-acute networks and collaboratives, and offers more robust agency profiles and guides, all sharable via text and email. By increasing patient satisfaction with the discharge process and reducing discharge delays, CarePort Guide brings a superior post-acute care selection tool to the market and can increase the number of patients attending in-network skilled nursing facilities by 7%. About WellSky® WellSky is one of America’s largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care. Our proven software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations scale processes, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to build healthy, thriving communities.

Read More

HEALTHCARE ANALYTICS

New Life Health & Concierge Selects eClinicalWorks EHR and healow for Improved Scalability, Reduced Costs, and Telehealth Services

Businesswire | May 29, 2023

eClinicalWorks®, the largest ambulatory cloud EHR, announced that New Life Health & Concierge, a primary care practice specializing in patient-centered concierge medicine, selected eClinicalWorks and healow to improve efficiency, drive patient acquisition, enhance patient engagement and lower costs. With eClinicalWorks and healow, the newly founded Fort Worth, TX based New Life Health & Concierge can leverage tools that will allow the company to spend more time focusing on improving and expanding their business and less time organizing their front and back office. In addition to eClinicalWorks Cloud EHR, healow® TeleVisits® helps the organization deliver in-office quality remotely, and improve safety, while also providing access to healthcare and convenience for patients and providers. “As a relatively new practice, we want to start off on the right foot and provide our patients with a seamless experience,” said Catherine C Wilson, FNP-BC of New Life Health & Concierge. “eClinicalWorks Cloud EHR provides us with the strong base we need to keep all the moving parts of starting a new business in line. eClinicalWorks makes it easy for our providers to keep up with the influx of new patients while organizing all their data and keeping costs low.” eClinicalWorks Project Kickstart helps startups like the New Life Health & Concierge thrive with Special pricing on eClinicalWorks’ suite of health IT features Marketing expertise, including website building, local SEO and social media Access to eClinicalWorks' top features, such as a fully integrated EMR and billing, PRISMA, online booking, healow TeleVisits and more. About eClinicalWorks eClinicalWorks was founded in 1999 to help digitize paper charts for ambulatory practices. Today, eClinicalWorks leads the nation in innovation with cloud-based solutions for Electronic Health Records and Practice Management. In addition, we help ambulatory practices, specialists, health centers, urgent care facilities, and hospital systems manage their revenue cycle, patient relationships, and Population Health initiatives. More than 150,000 providers and nearly 1 million medical professionals rely upon the power and scalability of the eCW Cloud for flexible clinical documentation, better front-office workflows, and more efficient billing driven by Robotic Process Automation. We combine innovation, leading-edge technology, and a commitment to patient safety to enable practices to grow and thrive amid the challenges of 21st-century healthcare

Read More

More featured news